Aerovate Therapeutics, Inc. | Business Contracts

Lease, dated April 26, 2022, by and between the Registrant and Hudson Metro Center, LLC (Filed With SEC on April 29, 2022)

Description of Securities (Filed With SEC on March 30, 2022)

Form of Underwriting Agreement (Filed With SEC on June 24, 2021)

Lease, dated August 6, 2021, by and between the Registrant and PDM 930 Unit, LLC (Filed With SEC on August 12, 2021)

Form of Amended and Restated Employment Agreement (Filed With SEC on June 17, 2021)

Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 17, 2021)

Non-Employee Director Compensation Policy (Filed With SEC on June 17, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on June 17, 2021)

2021 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on June 17, 2021)

Form of Specimen Common Stock Certificate (Filed With SEC on June 17, 2021)

2018 Equity Incentive Plan, and form of award agreements thereunder (Filed With SEC on June 9, 2021)

Offer Letter between the Registrant and Ralph Niven, dated April 26, 2020 (Filed With SEC on June 9, 2021)

Offer Letter between the Registrant and Hunter Gillies, dated April 27, 2020 (Filed With SEC on June 9, 2021)

Offer Letter between the Registrant and Benjamin T. Dake, dated November 4, 2019 (Filed With SEC on June 9, 2021)

Aerovate Therapeutics, Inc. (19)